Toward Combating Pseudomonas aeruginosa Infection, the Creation of Azithromycin Derivatives Based on a Trojan Horse Strategy
ChemMedChem · 2026
DOI: 10.1002/cmdc.70498 ↗At a glance
Journal article in ChemMedChem, 2026. Written by Aoi Kimishima and 10 co-authors. Institution: Graduate School of Infection Control Sciences, Kitasato University, Tokyo, Tokyo, Japan. Major MEDLINE topics: Pseudomonas aeruginosa, Azithromycin, Anti-Bacterial Agents, Pseudomonas Infections. 36 references. Funded by: Japan Agency for Medical Research and Development.
Abstract (original language)
Due to Pseudomonas aeruginosa ( P. aeruginosa )’s inherent resistance to many antibiotics and the increasing incidence of multidrug‐resistant (MDR) organisms, P. aeruginosa infection has become a growing global threat to humanity. Azithromycin (AZM) does not have prominent antibacterial activity against P. aeruginosa at a clinically reasonable level because of the bacteria’s outer membrane and efflux pump system; however, it does demonstrate other properties, including reduction of inflammation and suppression of P. aeruginosa virulence. With the promising potential of AZM as an anti‐ P. aeruginosa active compound, we proposed the application of a Trojan horse strategy to the synthesis of AZM derivatives. In this study, we designed and synthesized catechol‐conjugated AZM derivatives and evaluated their anti‐ P. aeruginosa activity. One of the derivatives showed superior antibacterial activity to AZM, even against MDR P. aeruginosa clinical isolates.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Graduate School of Infection Control Sciences, Kitasato University, Tokyo, Tokyo, Japan.
- Ōmura Satoshi Memorial Institute, Kitasato University, Tokyo, Tokyo, Japan.
- Department of Internal Medicine, Mount Carmel Health System, Grove City, Ohio, USA.
ORCID profiles: Aoi Kimishima, Taichi Kamo, Paul Wasuwanich, Naozumi Kondo, Yukihiro Asami
Funding
- Japan Agency for Medical Research and Development
Cite
APA
Kimishima, A., Suzuki, R., Kamo, T., Wasuwanich, P., Matsui, H., Negami, S., Honma, S., Ujie, Y., Kondo, N., Hanaki, H., & Asami, Y. (2026). Toward Combating Pseudomonas aeruginosa Infection, the Creation of Azithromycin Derivatives Based on a Trojan Horse Strategy. ChemMedChem. https://doi.org/10.1002/cmdc.70498
Vancouver
Kimishima A, Suzuki R, Kamo T, Wasuwanich P, Matsui H, Negami S, et al. Toward Combating Pseudomonas aeruginosa Infection, the Creation of Azithromycin Derivatives Based on a Trojan Horse Strategy. ChemMedChem. 2026. doi:10.1002/cmdc.70498
BibTeX
@article{Kimishima2026,
author = {Kimishima, Aoi and Suzuki, Rina and Kamo, Taichi and Wasuwanich, Paul and Matsui, Hidehito and Negami, Sota and Honma, Sota and Ujie, Yukiko and Kondo, Naozumi and Hanaki, Hideaki and Asami, Yukihiro},
title = {Toward Combating Pseudomonas aeruginosa Infection, the Creation of Azithromycin Derivatives Based on a Trojan Horse Strategy},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70498}
}
EUVIMED